This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon are part of the Zacks Industry Outlook article.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
Walgreens Boots (WBA) Benefits From Innovation Amid Margin Woe
by Zacks Equity Research
Walgreens Boots (WBA) continues to progress in transforming the pharmacy business and the method of delivering healthcare through physical stores and digital channels.
10 ETF Ideas for 2023
by Neena Mishra
We discuss best investment themes for the year.
5 Retail Stocks That Could Rally on Lower Inflation
by Shaun Pruitt
Consumer data showing signs of deflation on a month-to-month basis is promising for the broader stock market. This is especially significant for the Retail and Wholesale sector and a stronger consumer could lead to more upside in these five stocks.
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Walgreens Boots (WBA) Q1 Earnings Top, Revenues View Up
by Zacks Equity Research
The U.S. Healthcare segment of Walgreens Boots (WBA) grows on key contract wins, continued partnership growth and a strong focus on execution.
Walgreens Boots Alliance (WBA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 0.87% and 1.28%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Walgreens' (WBA) strategic executions on both the United States and the international front are likely to have contributed to the Q1 2023 top line.
Bears are Losing Control Over Walgreens (WBA), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Walgreens (WBA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Down -9.34% in 4 Weeks, Here's Why Walgreens (WBA) Looks Ripe for a Turnaround
by Zacks Equity Research
Walgreens (WBA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $37.58, marking a -1.91% move from the previous day.
Walgreens Boots Alliance (WBA) Stock Moves -0.41%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $38.44, marking a -0.41% move from the previous day.
Walgreens Boots (WBA) Gains From Digital Sales Amid Cost Woes
by Zacks Equity Research
Within the U.S. Healthcare segment, Walgreens Boots (WBA) is optimistic about the acquisition of CareCentrix.
Rite Aid (RAD) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 56.25% and 2.46%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $39.32 in the latest trading session, marking a +0.69% move from the prior day.
ETF Market Outlook & Investing Strategies for 2023
by Neena Mishra
We discuss the market outlook and investing strategies for 2023.
Top Research Reports for Verizon, Honeywell & CVS Health
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks,including Verizon Communications Inc. (VZ), Honeywell International Inc. (HON) and CVS Health Corporation (CVS).
Here's Why You Should Retain Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) led by strategic collaborations and noteworthy product launches.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $41.06, moving +1.56% from the previous trading session.
AmerisourceBergen (ABC) to Repurchase Common Stock Worth $200M
by Zacks Equity Research
AmerisourceBergen (ABC) announces a share repurchase worth $200 million in concurrence with the sale of its shares by one of its shareholders, Walgreens Boots Alliance, under Rule 144.
Walgreens Boots Alliance (WBA) Stock Moves -0.65%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $41.21 in the latest trading session, marking a -0.65% move from the prior day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $41.08 in the latest trading session, marking a +0.66% move from the prior day.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $41.76, moving -0.07% from the previous trading session.